Literature DB >> 25690120

Rare Varicella zoster virus infection in an ALT free flap.

Jun Ho Lee1, Hwan Jun Choi2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25690120      PMCID: PMC7950087          DOI: 10.1111/iwj.12425

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  4 in total

1.  Cutaneous reinnervation of the rectus abdominis musculocutaneous flap after chest wall reconstruction: development of herpes zoster in the transplanted musculocutaneous flap.

Authors:  K Tomita; K Inoue
Journal:  Ann Plast Surg       Date:  1998-08       Impact factor: 1.539

2.  Potentially lethal bacterial infection associated with varicella zoster virus.

Authors:  A J Pollard; A Isaacs; E G Hermione Lyall; N Curtis; K Lee; S Walters; M Levin
Journal:  BMJ       Date:  1996-08-03

3.  Varicella-zoster infection with secondary bacteremia and extensive facial abscesses.

Authors:  K G Lee; M O Cheng
Journal:  Med J Malaysia       Date:  2012-10

Review 4.  Varicella zoster virus (VZV)-human neuron interaction.

Authors:  Nicholas L Baird; Xiaoli Yu; Randall J Cohrs; Don Gilden
Journal:  Viruses       Date:  2013-09-04       Impact factor: 5.048

  4 in total
  3 in total

1.  Varicella zoster reactivation immediately following keystone flap reconstruction of a radiated back wound.

Authors:  Chan Woo Kim; Jeong Hyun Kim; Jang Won Lee; Tae Hwan Park
Journal:  Int Wound J       Date:  2018-09-21       Impact factor: 3.315

2.  Herpes Zoster Lesions on Reconstructed Breast Skin: Rare Objective Proof of Reinervation.

Authors:  Laurenz Weitgasser; Stephan Wolfgang Valina; Thomas Schoeller; Gudrun Ehebruster
Journal:  Arch Plast Surg       Date:  2017-01-20

Review 3.  Dermatologic Complications Following Cosmetic and Reconstructive Plastic Surgery: A Systematic Review of the Literature.

Authors:  Peter J Nicksic; Rebecca L Farmer; Samuel O Poore; Venkat K Rao; Ahmed M Afifi
Journal:  Aesthetic Plast Surg       Date:  2021-07-06       Impact factor: 2.326

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.